PD-L1 from GBM-EVs obtained from primary GBM lines participates in conversion of naïve and T helper cells to Treg, while expression of PD-1 and PD-L1 in Treg regulates their ability to inhibit function of effector T cells. This evidence concerns the gene CD274 and glioblastoma.